Senator Alli seeks collaboration with NACA for Oyo South

0
108

Senator Sharafadeen Alli (APC- Oyo South) has sought the collaboration of National Agency for Control of AIDS (NACA) towards enhancing the physical and mental well-being of his constituents and Oyo State.

He made the call during a courtesy call on the NACA’s Director-General, Dr. Temitope Ilori in her office.

Alli, who was earlier inaugurated as a member of the ECOWAS Parliament, was received by Dr. Ilori and other directors of the agency.

He said that the visit was aimed at fostering collaboration and partnership for the advancement and well-being of constituents as well as the broader Oyo State community.

The lawmaker pledged readiness to collaborate with NACA in various areas, including advocacy, campaigns, and other beneficial projects aimed at enlightening and enhancing the welfare of constituents in his senatorial district and Oyo State at large.

In her response, Dr. Ilori commended Senator Alli for his proactive approach in seeking collaboration with NACA to address critical issues such as HIV/AIDS, which remains a significant challenge in society.

She described the Senator’s initiative as a commendable move towards improving the well-being of constituents and joining the fight against the scourge of HIV/AIDS.

Dr. Ilori urged the lawmaker to incorporate NACA’s advocacy programmes and projects in his constituency development agenda to facilitate seamless collaboration and partnership between the agency and the senatorial district.

This strategic alignment is poised to enhance the effectiveness of efforts aimed at combating HIV/AIDS and promoting public health in Oyo South Senatorial District.

The collaborative efforts signify a proactive approach towards addressing pressing health challenges and advancing the socio-economic development of Oyo South Senatorial District.

By leveraging synergies and pooling resources, both parties are poised to achieve meaningful impact and foster sustainable development within the district and Oyo State.

LEAVE A REPLY

Please enter your comment!
Please enter your name here